Results 91 to 100 of about 2,896 (157)

Real-world comparative effectiveness of first-line BTK inhibitors in chronic lymphocytic leukemia. [PDF]

open access: yesFuture Oncol
Hou JZ   +16 more
europepmc   +1 more source

Zanubrutinib, obinutuzumab, and venetoclax in CLL: long-term follow up, MRD kinetics, retreatment, T-cell profiling, and PKs. [PDF]

open access: yesBlood Adv
Soumerai JD   +60 more
europepmc   +1 more source

Indirect Comparison of the Efficacy of Zanubrutinib vs Ibrutinib and Acalabrutinib in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-Up. [PDF]

open access: yesAdv Ther
Shadman M   +9 more
europepmc   +1 more source

Zanubrutinib and pirtobrutinib show synergistic killing and suppression of BTK signaling in MYD88-mutated lymphoma cells. [PDF]

open access: yesBlood Adv
Pizzarella D   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy